Kaizhen Wang

679 total citations
43 papers, 499 citations indexed

About

Kaizhen Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kaizhen Wang has authored 43 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Kaizhen Wang's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Membrane Separation Technologies (5 papers). Kaizhen Wang is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Membrane Separation Technologies (5 papers). Kaizhen Wang collaborates with scholars based in China, United States and Hong Kong. Kaizhen Wang's co-authors include Zhou Yong, Congjie Gao, Kuojun Zhang, Zhiqiang Peng, Xiangyu Zhang, Junfang Zheng, Kaifeng Gu, Qian Wang, Sheng Jiang and Xin Wang and has published in prestigious journals such as Advanced Functional Materials, Analytical Chemistry and The Science of The Total Environment.

In The Last Decade

Kaizhen Wang

40 papers receiving 493 citations

Peers

Kaizhen Wang
Comparison fields: 5 of 91
  • Molecular Biology 218
  • Cancer Research 140
  • Pulmonary and Respiratory Medicine 99
  • Oncology 96
  • Biomedical Engineering 85
Utsav Sen India
Runmei Li China
Xiaojiang Duan China
Bi‐Wen Yeh Taiwan
Qingying Wang China
Runzhi Zhu China
Xiaoping Wang China
Shusen Wang China
Yongming Zeng China
Utsav Sen India View profile →
Citations per field, relative to Kaizhen Wang
Kaizhen Wang · 1×
Citations per year, relative to Kaizhen Wang
Kaizhen Wang · 1×

Countries citing papers authored by Kaizhen Wang

Since Specialization
Citations

This map shows the geographic impact of Kaizhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaizhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaizhen Wang more than expected).

Fields of papers citing papers by Kaizhen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaizhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaizhen Wang. The network helps show where Kaizhen Wang may publish in the future.

Co-authorship network of co-authors of Kaizhen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kaizhen Wang. A scholar is included among the top collaborators of Kaizhen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaizhen Wang. Kaizhen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 FRA1 drives melanoma metastasis through an actionable transcriptional network Oncogene Xiaonan Xu, Kaizhen Wang et al. 0
2 Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy Journal of Medicinal Chemistry Yao Cheng, Kaizhen Wang et al. 1
3 Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancer Bioorganic & Medicinal Chemistry Letters Kaizhen Wang, Wanheng Zhang et al. 2
4 Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors Bioorganic Chemistry Jie Mao, Yuxing Wu et al. 2
5 Constructing natural phenolic acid mesopores to enhance chemotherapy and reduce accompanied intestinal damage Journal of Controlled Release Yuhang Miao, Kaizhen Wang et al. 1
6 PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis Cancer Research Xiaonan Xu, Kaizhen Wang et al. 8
7 Two‐Photon‐Activated Heavy‐Atom Free AIEgen for Highly Efficient Type I Photodynamic Therapy Advanced Functional Materials Ji Liu, Xinwen Ou et al. 26
8 Discovery of small molecules for autophagy-lysosome degradation of immune checkpoint proteins European Journal of Medicinal Chemistry Kaizhen Wang, Xiang Ni et al. 1
9 Discovery of novel phenyl urea SHP2 inhibitors with anti-colon cancer and potential immunomodulatory effects European Journal of Medicinal Chemistry Kaizhen Wang, Xiangyu Zhang et al. 2
10 PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability Cancer Research Xiaonan Xu, Yumi Kim et al. 4
11 Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1 Bioorganic Chemistry Kaizhen Wang, Hongtao Shen et al. 5
12 Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold European Journal of Medicinal Chemistry Kaizhen Wang, Ke Ye et al. 15
13 Diagnosing Orthotopic Lung Tumor Using a NTR-Activatable Near-Infrared Fluorescent Probe by Tracheal Inhalation Analytical Chemistry Jun Yan, Kaizhen Wang et al. 15
14 Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis Cancer Research Xiaonan Xu, Kaizhen Wang et al. 7
15 Ultra-low pressure PES ultrafiltration membrane with high-flux and enhanced anti-oil-fouling properties prepared via in-situ polycondensation of polyamic acid The Science of The Total Environment Kaizhen Wang, Shuhao Wang et al. 17
16 Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer Journal of Medicinal Chemistry Kuojun Zhang, Kaizhen Wang et al. 22
17 A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2 Cancers Olga Vera, Koji Nakamura et al. 22
18 Liposomal N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis RSC Advances Kaizhen Wang, Zhiqiang Zhuo et al. 6
19 Sedentary Behavior Predicts Changes in Cardiometabolic Risk in Professional Workers Journal of Occupational and Environmental Medicine Zhixiong Zhou, Fan Zhang et al. 11
20 Study of establishing lymphoma diagnostic model by SELDI-TOF-MS Chinese Clinical Oncology Kaizhen Wang 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026